Effect of a 5-lipoxygenase inhibitor on nerve growth factor-induced thermal hyperalgesia in the rat.

Abstract

Intraplantar injection of mouse beta (2.5S) nerve growth factor (NGF) caused thermal hyperalgesia and stimulated release of immunoreactive leukotriene B4 from the rat paw skin. Both effects of NGF were prevented by the 5-lipoxygenase inhibitor, (R)-2-[4-quinolin-2-yl-methoxy)phenyl]-2-cyclopentyl acetic acid (BAY X1005). BAY X1005 did not affect bradykinin-induced thermal hyperalgesia. These results suggest the participation of 5-lipoxygenase products of arachidonate in NGF-induced local thermal hyperalgesia.

• Authors: R Amann, R Schuligoi, I Lanz, B A Peskar
• Journal: European journal of pharmacology (Eur J Pharmacol) Vol. 306 Issue 1-3 Pg. 89-91 (Jun 13 1996) ISSN: 0014-2999 [Print] Netherlands
• PMID: 8813619 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Lipoxygenase Inhibitors
• Nerve Growth Factors
• Quinolines
• 2-(4-(quinolin-2-yl-methoxy)phenyl)-2-cyclopentylacetic acid
• Leukotriene B4

Topics

• Animals
• Hot Temperature
• Hyperalgesia (chemically induced, prevention & control)
• Leukotriene B4 (agonists, antagonists & inhibitors, metabolism)
• Lipoxygenase Inhibitors (pharmacology)
• Male
• Nerve Growth Factors (antagonists & inhibitors)
• Pain Threshold (drug effects)
• Quinolines (pharmacology)
• Rats
• Rats, Sprague-Dawley